全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Rethinking Fluid Management in Congestive Heart Failure: Cardiovascular-Renal Regulation, Fluid Management and Diuretics

DOI: 10.4236/wjcd.2026.163018, PP. 177-181

Keywords: Cardiovascular-Renal System, Fluid Management, Diuretics

Full-Text   Cite this paper   Add to My Lib

Abstract:

Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is commonly treated as the primary driver of decompensation, with chronic diuretic therapy serving as the cornerstone of outpatient management. However, many patients admitted with CHF exacerbation are already receiving escalating doses of diuretics, raising important questions regarding the underlying mechanisms of recurrent decompensation. This perspective proposes a systems-based, hypothesis-generating framework that reframes congestion as a downstream manifestation of impaired cardiovascular-renal regulation rather than a primary disorder of fluid excess. We examine how rigid, protocol-driven approaches to diuretic use may disrupt physiological equilibrium in susceptible patients and contribute to instability, neurohormonal overactivation, and readmission. We further discuss practice gaps in outpatient fluid management, including inconsistent application of fluid restriction and limited attention to individual tolerance. Finally, we outline the rationale for an individualized, patient-centered approach to fluid management that complements existing guideline-based therapies and warrants prospective investigation.

References

[1]  Heidenreich, P.A., Fonarow, G.C., Opsha, Y., Sandhu, A.T., Sweitzer, N.K., Warraich, H.J., et al. (2022) Economic Issues in Heart Failure in the United States. Journal of Cardiac Failure, 28, 453-466.
https://doi.org/10.1016/j.cardfail.2021.12.017
[2]  Virani, S.S., Alonso, A., Benjamin, E.J., et al. (2020) Heart Disease and Stroke Statistics—2020 Update. Circulation, 141, e139-e596.
[3]  Heidenreich, P.A., Albert, N.M., Allen, L.A., Bluemke, D.A., Butler, J., Fonarow, G.C., et al. (2013) Forecasting the Impact of Heart Failure in the United States. Circulation: Heart Failure, 6, 606-619.
https://doi.org/10.1161/hhf.0b013e318291329a
[4]  Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Drazner, M.H., et al. (2013) 2013 ACCF/AHA Guideline for the Management of Heart Failure. Circulation, 128, e240-e327.
https://doi.org/10.1161/cir.0b013e31829e8776
[5]  Heidenreich, P.A., Bozkurt, B., Aguilar, D., Allen, L.A., Byun, J.J., Colvin, M.M., et al. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e895-e1032.
https://doi.org/10.1161/cir.0000000000001063
[6]  Ahmed, A., Husain, A., Love, T.E., Gambassi, G., Dell’Italia, L.J., Francis, G.S., et al. (2006) Heart Failure, Chronic Diuretic Use, and Increase in Mortality and Hospitalization: An Observational Study Using Propensity Score Methods. European Heart Journal, 27, 1431-1439.
https://doi.org/10.1093/eurheartj/ehi890
[7]  Cayley Jr., W.E. (2006) Diuretics for Treatment Of patients with Heart Failure? American Family Physician, 74, 411-413.
[8]  Kapelios, C.J., Canepa, M., Savarese, G. and Lund, L.H. (2021) Use of Loop Diuretics in Chronic Heart Failure: Do We Adhere to the Hippocratian Principle ‘Do No Harm’? European Journal of Heart Failure, 23, 1068-1075.
https://doi.org/10.1002/ejhf.2214
[9]  Cuthbert, J.J. and Clark, A.L. (2024) Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions—Part I: Loop Diuretics. Current Heart Failure Reports, 21, 101-114.
https://doi.org/10.1007/s11897-024-00643-3
[10]  Seid, M.A., Abdela, O.A. and Zeleke, E.G. (2019) Adherence to Self-Care Recommendations and Associated Factors among Adult Heart Failure Patients. From the Patients’ Point of View. PLOS ONE, 14, e0211768.
https://doi.org/10.1371/journal.pone.0211768
[11]  Wang, D. and Wang, J. (2024) Congestive Heart Failure: Treatment of Symptoms or Causes. World Journal of Cardiovascular Diseases, 14, 480-489.
https://doi.org/10.4236/wjcd.2024.148041
[12]  van Walraven, C., Jennings, A. and Forster, A.J. (2011) A Meta-Analysis of Hospital 30-Day Avoidable Readmission Rates. Journal of Evaluation in Clinical Practice, 18, 1211-1218.
https://doi.org/10.1111/j.1365-2753.2011.01773.x
[13]  Kwok, C.S., Abramov, D., Parwani, P., Ghosh, R.K., Kittleson, M., Ahmad, F.Z., et al. (2021) Cost of Inpatient Heart Failure Care and 30-Day Readmissions in the United States. International Journal of Cardiology, 329, 115-122.
https://doi.org/10.1016/j.ijcard.2020.12.020

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133